EC Amends Implementation Schedule for Collateral Exchange Requirements
EC published Regulation 2021/236, which amends the technical standards laid down in Regulation 2016/2251, with respect to the timing for application of certain risk management procedures for the exchange of collateral. The amended regulation addresses the one-year extension of the deadline for implementation of initial margin requirements for certain counterparties. Regulation 2021/236shall enter into force on the day following that of its publication in the Official Journal of the European Union.
Regulation 2016/2251, which is being amended, provides for a phase-in of the initial margin requirements over a number of years based on the implementation schedule agreed by BCBS and IOSCO. BCBS and IOSCO recently amended their schedule for the implementation of requirements for the exchange of collateral. This amendment to the implementation schedule of BCBS and IOSCO should be reflected in the phase-in provided for in Regulation 2016/2251. In the interest of supporting a smooth and orderly implementation of margin requirements across members of BCBS and IOSCO and to avoid market fragmentation, the deadline for the implementation of the initial margin requirements has been extended by one year for counterparties with an aggregate average notional amount of non-centrally cleared derivatives between EUR 8 billion and EUR 50 billion. As part of the phase-in, counterparties with an aggregate average notional amount of non-centrally cleared derivatives above EUR 50 billion shall be subject to the initial margin requirements from September 01, 2021. Additionally, counterparties with an aggregate average notional amount of non-centrally cleared derivatives above EUR 8 billion shall be subject to the initial margin requirements from September 01, 2022.
Regulation 2016/2251 provides for a deferred date of application of the bilateral margin requirements for non-centrally cleared over-the-counter (OTC) derivative contracts concluded between counterparties that are part of the same group and where one counterparty is established in a third country and the other counterparty is established in EU. UK became a third country on February 01, 2020. Counterparties cannot predict what the status of a counterparty established in UK might become or to what extent that counterparty would be able to continue providing certain services to the counterparties established in EU. To ensure a smooth functioning of the market and a level playing field between counterparties established in EU, counterparties should be able to replace counterparties established in UK with counterparties in a member state without being required to exchange collateral in respect of those novated contracts. In addition, counterparties should be given sufficient time to replace their counterparties established in UK. Thus, the date from which the requirement to exchange collateral may be triggered for the novation of those contracts has been deferred, as part of these amendments to Regulation 2016/2251.
Related Links
Effective Date: February 18, 2021
Keywords: Europe, EU, Banking, Securities, Implementation Schedule, Initial Margin, OTC Derivatives, Regulation 2016/2251, Counterparty Risk, Market Risk, Basel, Regulation 2021/236, BCBS, IOSCO, EC
Featured Experts

María Cañamero
Skilled market researcher; growth strategist; successful go-to-market campaign developer

Pierre-Etienne Chabanel
Brings expertise in technology and software solutions around banking regulation, whether deployed on-premises or in the cloud.

Nicolas Degruson
Works with financial institutions, regulatory experts, business analysts, product managers, and software engineers to drive regulatory solutions across the globe.
Related Articles
APRA Finalizes Reporting Standard for Operational Risk Requirements
APRA finalized the reporting standard ARS 115.0 on capital adequacy with respect to the standardized measurement approach to operational risk for authorized deposit-taking institutions in Australia.
ECB Publishes Guide for Determining Penalties for Regulatory Breaches
ECB published a guide that outlines the principles and methods for calculating the penalties for regulatory breaches of prudential requirements by banks.
MAS Sets Out Good Practices to Manage Operational Risks Amid COVID
MAS and The Association of Banks in Singapore (ABS) jointly issued a paper that sets out good practices for the management of operational and other risks stemming from new work arrangements adopted by financial institutions amid the COVID-19 pandemic.
ACPR Announces New Data Collection Application for Banks and Insurers
ACPR announced that a new data collection application, called DLPP (Datalake for Prudential), for collecting banking and insurance prudential data will go into production on April 12, 2021.
BCB Maintains CCyB at 0%, Initiates First Cycle of Regulatory Sandbox
BCB announced that the Financial Stability Committee decided to maintain the countercyclical capital buffer (CCyB) for Brazil at 0%, at least until the end of 2021.
EBA Consults on Pillar 3 Disclosure Standards for ESG Risks Under CRR
EBA is consulting on the implementing technical standards for Pillar 3 disclosures on environmental, social, and governance (ESG) risks, as set out in requirements under Article 449a of the Capital Requirements Regulation (CRR).
ESAs Issue Advice on KPIs on Sustainability for Nonfinancial Reporting
ESAs Issue Advice on KPIs on Sustainability for Nonfinancial Reporting
EIOPA Launches Study on Non-Life Underwriting Risk in Internal Models
EIOPA has launched a European-wide comparative study on non-life underwriting risk in internal models, also kicking-off of the data collection phase.
SRB Publishes Overview of Resolution Tools Available in Banking Union
SRB published an overview of the resolution tools available in the Banking Union and their impact on a bank’s ability to maintain continuity of access to financial market infrastructure services in resolution.
EU Amends CRD4 and CRD5 as Part of Capital Markets Recovery Package
EU published Directive 2021/338, which amends the Markets in Financial Instruments Directive (MiFID) II and the Capital Requirements Directives (CRD 4 and 5) to facilitate recovery from the COVID-19 crisis.